Your browser doesn't support javascript.
loading
Analysis of four scales for global severity evaluation in Parkinson's disease.
Martínez-Martín, Pablo; Rojo-Abuin, Jose Manuel; Rodríguez-Violante, Mayela; Serrano-Dueñas, Marcos; Garretto, Nélida; Martínez-Castrillo, Juan Carlos; Arillo, Víctor Campos; Fernández, William; Chaná-Cuevas, Pedro; Arakaki, Tomoko; Alvarez, Mario; Ibañez, Ivonne Pedroso; Rodríguez-Blázquez, Carmen; Chaudhuri, Kallol Ray; Merello, Marcelo.
Afiliação
  • Martínez-Martín P; National Center of Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid, Spain.
  • Rojo-Abuin JM; Department of Statistics, Centre of Human and Social Sciences, Spanish Council for Scientific Research, Madrid, Spain.
  • Rodríguez-Violante M; Movement Disorders Unit, Instituto Nacional de Neurologia y Neurocirugia, Mexico , Mexico.
  • Serrano-Dueñas M; Movement Disorder and Biostatistics Units, Neurological Service, Carlos Andrade Marín Hospital and Medicine Faculty, Pontifical Catholic University of Ecuador, Quito, Ecuador.
  • Garretto N; Department of Neurology, Hospital Ramos Mejia, Centro Universitario de Neurología de la Universidad de Buenos Aires (UBA), Buenos Aires, Argentina.
  • Martínez-Castrillo JC; Movement Disorders Unit, Department of Neurology, Hospital Ramon y Cajal, IRYCIS, Madrid, Spain.
  • Arillo VC; Movement Disorders Unit, Department of Neuroscience, Hospital Xanit International, Benalmádena (Málaga), Spain.
  • Fernández W; Movement Disorders Unit, Department of Neurology, Universidad Nacional de Colombia, Bogotá, Colombia.
  • Chaná-Cuevas P; CETRAM, Facultad de Ciencias Médicas, Universidad de Santiago de Chile, Santiago, Chile.
  • Arakaki T; Department of Neurology, Hospital Ramos Mejia, Centro Universitario de Neurología de la Universidad de Buenos Aires (UBA), Buenos Aires, Argentina.
  • Alvarez M; Department of Movement Disorders and Neurodegeneration, CIREN, La Habana, Havana, Cuba.
  • Ibañez IP; Department of Movement Disorders and Neurodegeneration, CIREN, La Habana, Havana, Cuba.
  • Rodríguez-Blázquez C; National Center of Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid, Spain.
  • Chaudhuri KR; National Parkinson Foundation International Centre of Excellence, King's College Hospital, King's College, London, UK.
  • Merello M; Movement Disorders Section, Raul Carrea Institute for Neurological Research (FLENI), Buenos Aires, Argentina.
NPJ Parkinsons Dis ; 2: 16007, 2016.
Article em En | MEDLINE | ID: mdl-28725695
Global evaluations of Parkinson's disease (PD) severity are available, but their concordance and accuracy have not been previously tested. The present international, cross-sectional study was aimed at determining the agreement level among four global scales for PD (Hoehn and Yahr, HY; Clinical Global Impression of Severity, CGIS; Clinical Impression of Severity Index, CISI-PD; and Patient Global Impression of Severity, PGIS) and identifying which of them better correlates with itemized PD assessments. Assessments included additional scales for evaluation of the movement impairment, disability, affective disorders, and quality of life. Spearman correlation coefficients, weighted and generalized kappa, and Kendall's concordance coefficient were used. Four hundred thirty three PD patients, 66% in HY stages 2 or 3, mean disease duration 8.8 years, were analyzed. Correlation between the global scales ranged from 0.60 (HY with PGIS) to 0.91 (CGIS with CISI-PD). Kendall's coefficient of concordance resulted 0.76 (P<0.0001). HY and CISI-PD showed the highest association with age, disease duration, and levodopa-equivalent daily dose, and CISI-PD with measures of PD manifestations, disability, and quality of life. PGIS and CISI-PD correlated similarly with anxiety and depression scores. The lowest agreement in classifying patients as mild, moderate, or severe was observed between PGIS and HY or CISI-PD (58%) and the highest between CGIS and CISI-PD (84.3%). The four PD global severity scales agree moderately to strongly among them; clinician-based ratings estimate PD severity, as established by other measures, better than PGIS; and the CISI-PD showed the highest association with measures of impairment, disability, and quality of life.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article